HCV Infections
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Pharmacokinetic Study of the HCV Protease Inhibitor Bo-cePRevir and the Proton Pump Inhibitor OMeprazOle (PROMO) (NCT01470690) | Radboud University Medical Center | 2011-10-01 |
| Pharmacokinetic Study of the HCV Protease Inhibitor Boceprevir and the HIV Integrase Inhibitor Raltegravir (NCT01288417) | Radboud University Medical Center | 2011-08-01 |
| A Study of Single Dose of ABT-333 in Healthy Male Adults (NCT00919490) | Abbott | 2009-06-01 |
Track HCV Infections automatically
Every clearance here is in the API, with alerts when new ones post.